Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
PRESS RELEASE: Boston Life Sciences Readies Altropane Trials
PRESS RELEASE: Boston Life Sciences Readies Altropane Trials Boston Business Journal 12:06 PM EST Thursday April 1, 2004 Boston Life Sciences Inc. and the FDA have finalized an agreement as to how the company will conduct a new Phase III clinical trial for its radio-imaging agent Altropane. The agent is intended to help doctors differentiate among tremors caused by Parkinson's disease or other factors. Boston Life Sciences plans to enroll at least 500 people in 25 centers across the United States, split evenly between those who have Parkinsonian tremors and non-Parkinsonian tremors. Boston Life Sciences is developing treatments and diagnostic products for central nervous system diseases and cancer. SOURCE: Boston Business Journal, MA * * * ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:listserv@xxxxxxxxxxxxxxxxxxxx In the body of the message put: signoff parkinsn
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance
